ADXN Stock Analysis: Buy, Sell, or Hold?
ADXN - Addex Therapeutics Ltd American Depositary Shares
$5.20
-0.39 (-7.06%)
▼
5d:
-8.69%
30d:
-16.13%
90d:
-27.78%
HOLD
MODERATE Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Jun 15, 2026
0d
Get Alerted When ADXN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ADXN shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: ADXN shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: ADXN is currently trading at $5.20, which is considered oversold relative to its 30-day fair value range of $5.57 to $6.07.
Technical Outlook: Technically, ADXN is in a downtrend. Immediate support is located at $5.04, while resistance sits at $6.45. Short-term momentum is weak, with the stock down 7.1% recently.
Market Sentiment: ADXN has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $30.00 (+476.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ADXN is in a downtrend. Immediate support is located at $5.04, while resistance sits at $6.45. Short-term momentum is weak, with the stock down 7.1% recently.
Market Sentiment: ADXN has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $30.00 (+476.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$5.57 -
$6.07
Company Quality Score
46/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-7.1%)
- BULLISH: Trading 476.9% below Wall St target ($30.00)
- CAUTION: 5-day price weakness (-8.7%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$5.57 -
$6.07
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$5.04
Resistance Level
$6.45
Current Trend
Downtrend
Technical data as of
Jul 31, 2026
Fundamental Context
Wall Street Target
$30.00
(+476.9%)
Revenue Growth (YoY)
-89.2%
Share & Embed Analysis
Last updated: August 04, 2026 8:47 AM ET
Data refreshes hourly during market hours. Next update: 9:47 AM
Data refreshes hourly during market hours. Next update: 9:47 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ADXN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$26 | 50 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1080 | 57 HOLD |
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 45 HOLD |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$52 | 52 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
